Researchers from Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center (BMC) reviewed cancer ...

In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

Beyond avoiding cavities and gum disease, a new study finds good oral hygiene also protects against head and neck cancer.

Cancer researchers analyzed records from 160,000 patients to find that germs may influence the potential for a relatively ...

Failing to brush your teeth regularly could put you at a greater risk for head and neck cancer, which kills more than 4,000 ...

The KEYNOTE-689 study evaluating pembrolizumab in this patient population met its primary end point of event-free survival.

Keytruda succeeds n a Phase 3 trial for head and neck cancer, showing promising results for event-free survival, the study's ...

Merck's Keytruda (pembrolizumab) met primary endpoint of event-free survival (EFS) in Phase 3 trial for newly diagnosed head ...

A major UK-wide audit into head and neck cancers is about to get under way with backing from leading specialist charity Get A ...

In the U.S., millions of people experience cancer every year but don't have an equal opportunity to access experimental treatments in clinical trials, or to receive treatments that were shown to be ...